Achillion Pharmaceuticals, Inc.
(NASDAQ : ACHN)

( )
ACHN PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.25%80.150.9%$597.90m
CELGCelgene Corporation
0.57%137.491.1%$551.15m
AMGNAmgen Inc.
0.00%181.901.1%$427.51m
BIIBBiogen Inc.
0.00%335.681.2%$368.45m
REGNRegeneron Pharmaceuticals, Inc.
0.00%445.682.7%$321.88m
ALNYAlnylam Pharmaceuticals, Inc
0.00%121.8910.7%$270.07m
VRTXVertex Pharmaceuticals Incorporated
0.00%154.701.9%$225.87m
INCYIncyte Corporation
0.00%116.602.5%$209.70m
ALXNAlexion Pharmaceuticals, Inc.
0.00%140.841.9%$178.28m
ILMNIllumina, Inc.
0.00%206.233.5%$141.08m
EXELExelixis, Inc.
0.28%29.106.5%$134.60m
CLVSClovis Oncology, Inc.
0.00%84.5816.5%$131.34m
BLUEBluebird Bio, Inc.
0.84%144.5017.3%$123.02m
SRPTSarepta Therapeutics, Inc.
0.00%50.7316.9%$110.70m
BMRNBioMarin Pharmaceutical Inc.
0.00%94.664.4%$104.77m

Company Profile

Achillion Pharmaceuticals, Inc. engages in the research and development of small molecule drug therapies for infectious diseases and immune system disorders. It intends to commercialize its anti-viral medicines for the treatment of hepatitis C and resistant bacterial infections. The company was founded on August 17, 1998 and is headquartered in New Haven, CT.